Brazilian SARS-CoV-2 P.1 variant shows resistance to antibody neutralization
Researchers in the United States say the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant – P.1 – that has recently emerged in Brazil shows […]
Home »
The REal-time Assessment of Community Transmission-2 (REACT-2) program completed its fifth round of community surveys in the days between January 26 and February 8, 2021. […] Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) […] COVID-19 has caused millions of more illnesses than its predecessor, SARS, even though both diseases are caused by similar coronaviruses. Now, a new study suggests […] As newly developed vaccines against coronavirus disease 2019 (COVID-19) are being rolled out worldwide, several regions have seen the rise of vaccine hesitancy or unwillingness. […] As the world continues to seek solutions in response to the coronavirus pandemic, Beckman Coulter Life Sciences announces it is the first United States distributor […] Thought LeadersDr. Natalia FreundAssistant Professor, Sackler School of MedicineTel Aviv University In this interview, News-Medical speaks to Dr. Natalia Freund about her latest research into […] Researchers in the United States have conducted a study suggesting that individuals who have recovered from or been vaccinated against severe acute respiratory syndrome coronavirus […] Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), millions of people have died, […] The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is causing the current pandemic of coronavirus disease 2019 (COVID-19), has been the object of intense […]
One in seven people in England show SARS-CoV-2 antibodies, finds study
FDA issues EUA for third COVID-19 vaccine
Why COVID-19 spreads more easily than SARS
AI-mediated analysis of vaccinated patients affirms safety of SARS-CoV-2 vaccines
Beckman Coulter Life Sciences established as first us distributor of genedrive plc COVID-19 kit
Are antibody cocktails the key to COVID-19 treatment?
Convalescent plasma shows CD8+ T cell responses to SARS-CoV-2 variants
The impact of SARS-CoV-2 on pregnancy in Nordic countries
Inhibition of protein glycosylation successfully prevents SARS-CoV-2 infection in vitro